Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

HSV529

Vaccine · Immune activation

Phase 1 Most advanced trial (none active)

What is HSV529?

HSV529 is a vaccine administered intramuscularly in the deltoid muscle as a 0.5 mL solution containing 1 x 10(7) plaque forming units.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Vaccine
Mechanism
Immune activation
Therapy area
Infectious disease
In trials of
SNY
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1
UNII
EXF2K5XEC4

Conditions studied

Healthy Volunteers

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.